DEPARTMENT OF MICROBIOLOGY & IMMUNOLOGY, NATIONAL CHENG KUNG UNIVERSITY, TAIWAN
Area: RESEARCH & INDUSTRY, INCUBATION
Booth No: N416
Website: https://web.ncku.edu.tw/
Exhibitor Profile
Our team has developed a novel live-attenuated influenza vaccine containing an NS1 mutant (patents granted in Taiwan, the USA, and China). Preclinical studies demonstrated the safety, high interferon-inducing activity, and cross-protection. We aim to implement this NS1 mutant design into other live-attenuated influenza vaccines, such as cold-adaptive strains like Flumist/Fluenz (AstraZeneca) and Nasovac (Biodiem), to boost their effectiveness and better protect against flu epidemics.
Exhibitors you may be interested in
Highest Rated